Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Candidiasis"
Show Display Options
Rank Status Study
1 Unknown  Invasive Candidiasis in ICU
Condition: Invasive Candidiasis
2 Recruiting CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Condition: Candidiasis, Chronic Mucocutaneous
Intervention: Drug: Amphotericin B
3 Recruiting Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
Condition: Candidiasis, Invasive
Interventions: Drug: Caspofungin;   Drug: Amphotericin B Deoxycholate
4 Not yet recruiting Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis
Condition: Vulvovaginal Candidiasis
Interventions: Device: LactiSal vaginal gel 1%;   Device: LactiSal vaginal tablet 50mg;   Drug: Clotrimazole vaginal tablet 100mg
5 Recruiting Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis
Condition: Vulvo-vaginal Candidiasis
Interventions: Dietary Supplement: Saccharomyces cerevisiae;   Dietary Supplement: Placebo
6 Not yet recruiting Fluconazole Versus Micafungin in Neonates With Candidiasis
Condition: Candidiasis
Interventions: Drug: Fluconazole;   Drug: Micafungin
7 Recruiting Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.
Condition: Invasive Candidiasis; Treatment With Echinocandin
Interventions: Biological: Blood sample taken on the day the treatment is initiated;   Biological: Blood sample taken on day 3 after initiation of treatment;   Biological: Blood sample taken on day 5 after initiation of;   Biological: Blood sample taken on day 7 after initiation of treatment;   Biological: Blood sample taken on day 10 after initiation of treatment
8 Unknown  Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis
Conditions: Candidiasis;   Bacterial Vaginosis
Interventions: Drug: Clindamycin 100mg and Ketoconazole 400mg;   Drug: Tetracycline 100mg and Amphotericin B 50mg
9 Recruiting Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
Conditions: Invasive Fungal Disease;   Chronic Disseminated Candidiasis;   Hematological Malignancies;   Hematopoietic Stem Cell Transplantation;   Neutropenia
Intervention: Device: 18F-FDG PET Scan
10 Unknown  A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China
Condition: Candidiasis
11 Not yet recruiting A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.
Condition: Oropharyngeal Candidiasis
Interventions: Drug: Unique Pharmaceutical Laboratories, India;   Drug: Roxane Laboratories Inc., USA
12 Recruiting RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
Conditions: Candidiasis, Vulvovaginal;   Mycoses;   Yeast Infection;   Moniliasis, Vulvovaginal;   Vaginitis, Monilial
Interventions: Drug: CD101 gel (3%);   Drug: CD101 gel (1%);   Drug: CD101 ointment (6%);   Drug: CD101 ointment (1%);   Drug: Fluconazole
13 Recruiting Pharmacokinetics of Micafungin in Critically Ill Patients
Conditions: Critical Illness;   Invasive Candidiasis
14 Recruiting Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
Conditions: Microbiome;   Antibiotic-Induced VVC;   Vaginal Candidiasis
15 Recruiting Studies of Disorders With Increased Susceptibility to Fungal Infections
Conditions: Primary Immune Deficiency;   Candida;   Autoimmune Polyendocrinopathy Candidiasis Ectodermal;   Chronic Mucocutaneous Candidiasis (CMC);   Fungal Infection
16 Recruiting Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis
Condition: Candidiasis, Vulvovaginal
Interventions: Device: Saccharomyces cerevisiae;   Device: Placebo
17 Recruiting PEACE: Pediatric Antifungal Comparative Effectiveness
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
18 Not yet recruiting Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients
Condition: Candida Infections
19 Recruiting Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
Conditions: Candidiasis;   Vaginosis, Bacterial
Interventions: Device: Boric acid and probiotics;   Drug: Antibiotic (Clindamycin);   Drug: Antifungal (Clotrimazole)
20 Unknown  Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
Condition: Pulmonary Candidiasis
Intervention: Drug: fluconazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years